Skip to content

Author

Weiren Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Complement C5a Fosters Tumor-promoting Immunity by Recruiting regulatory T cells in hepatocellular carcinoma.

Findings reveal that cancer cell-derived anaphylatoxin C5a plays a pivotal role in promoting an inhibitory TIME in liver tumor tissues and blocking the C5a/C5ar1 axis in combination with immune checkpoint inhibitors could represent a promising strategy for treating HCC.

Run Huang, Tian-Hao Chu, Guiqi Zhu et al. · 0 citations
Open access Jul 2026

Metabolic Reprogramming of NSUN2-Mediated m5C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity

It is suggested that NSUN2 could represent a critical nexus between m5C RNA methylation and immunosuppression, providing a therapeutic rationale for combination immunotherapy in HCC.

Sheng-Wei Mao, Yuan-Yuan Fang, Jun Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.